HealthTechCrunch34 minutes ago
Enveda Raises $311M for AI Drug Discovery
2 min read
Enveda, a biotech startup using AI to find drugs in plants and microbes, raised a $311 million Series E led by Catalio Capital Management at a $2 billion valuation, doubling its valuation from 12 months ago. The company is testing drugs for severe skin conditions and weight-loss maintenance after GLP-1s.
Level
Hype check
Tap to vote and see what everyone thinks.
